CY1113943T1 - Παρασκευασμα κατακρατησης 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινολης - Google Patents
Παρασκευασμα κατακρατησης 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινοληςInfo
- Publication number
- CY1113943T1 CY1113943T1 CY20131100328T CY131100328T CY1113943T1 CY 1113943 T1 CY1113943 T1 CY 1113943T1 CY 20131100328 T CY20131100328 T CY 20131100328T CY 131100328 T CY131100328 T CY 131100328T CY 1113943 T1 CY1113943 T1 CY 1113943T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hours
- weight
- active substance
- dimethylaminmythyl
- cycoloxyl
- Prior art date
Links
- 239000013543 active substance Substances 0.000 abstract 3
- JIRYWFYYBBRJAN-UHFFFAOYSA-N 3-[2-[(dimethylamino)methyl]cyclohexyl]phenol Chemical compound CN(C)CC1CCCCC1C1=CC=CC(O)=C1 JIRYWFYYBBRJAN-UHFFFAOYSA-N 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- JIRYWFYYBBRJAN-ZFWWWQNUSA-N faxeladol Chemical compound CN(C)C[C@@H]1CCCC[C@H]1C1=CC=CC(O)=C1 JIRYWFYYBBRJAN-ZFWWWQNUSA-N 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pretreatment Of Seeds And Plants (AREA)
Abstract
Η εφεύρεση αφορά σε μία μορφή χορήγησης για την ελεγχόμενη απελευθέρωση της δραστικής ουσίας 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινόλης, κατά προτίμηση (1R, 2R)- 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο)φαινόλης, ή ενός των φαρμακευτικά υποφερτών αλάτων της, η οποία (i) in vivo μετά από 2 έως 10 h επιτυγχάνει την μέγιστη τιμή επιπέδου πλάσματος της δραστικής ουσίας, και/ή (ii) in vitro, μετρημένη σύμφωνα με την Ευρωπαϊκή Φαρμακευτική Βίβλο με μια συσκευή ανάδευσης πτερυγίου σε ρυθμιστικό διάλυμα σε μια τιμή ρΗ 6,8 (κατά προτίμηση 900 ml), μία θερμοκρασία 37°C και 75 σ.α.λ. απελευθερώνει: μετά από 0,5 ώρες 3,0 έως 37% κ.β., μετά από 1 ώρα 5,0 έως 56%κ.β., μετά από 2 ώρες 10 έως 77%κ.β., μετά από 3 ώρες 15 έως 88% κ.β., μετά από 6 ώρες τουλάχιστον 30% κ.β., μετά από 12 ώρες τουλάχιστον 50% κ.β., μετά από 18 ώρες τουλάχιστον 70% κ.β. και μετά από 24 ώρες τουλάχιστον 80% κ.β. της αρχικά περιεχόμενης στη μορφή χορήγησης δραστικής ουσίας.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005044212 | 2005-09-15 | ||
| EP06805729A EP1928441B1 (de) | 2005-09-15 | 2006-09-15 | Retardformulierung von 3-(2-dimethylaminomethyl-cyclohexyl)-phenol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113943T1 true CY1113943T1 (el) | 2016-07-27 |
Family
ID=37744782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100328T CY1113943T1 (el) | 2005-09-15 | 2013-04-23 | Παρασκευασμα κατακρατησης 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινολης |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20090104266A1 (el) |
| EP (1) | EP1928441B1 (el) |
| JP (1) | JP2009507875A (el) |
| KR (1) | KR20080059212A (el) |
| CN (1) | CN101262857A (el) |
| AU (1) | AU2006291422B2 (el) |
| BR (1) | BRPI0621466A2 (el) |
| CA (1) | CA2621270A1 (el) |
| CY (1) | CY1113943T1 (el) |
| DK (1) | DK1928441T3 (el) |
| EC (1) | ECSP088285A (el) |
| ES (1) | ES2402206T3 (el) |
| HR (1) | HRP20130225T1 (el) |
| IL (1) | IL189820A0 (el) |
| NO (1) | NO20081785L (el) |
| NZ (1) | NZ566473A (el) |
| PL (1) | PL1928441T3 (el) |
| PT (1) | PT1928441E (el) |
| RU (1) | RU2445081C2 (el) |
| SI (1) | SI1928441T1 (el) |
| WO (1) | WO2007031326A2 (el) |
| ZA (1) | ZA200802269B (el) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10356362A1 (de) * | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
| EP2085081A1 (de) * | 2008-02-04 | 2009-08-05 | Grünenthal GmbH | 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz |
| CN108289848A (zh) * | 2015-12-08 | 2018-07-17 | 阿迪亚生命科学公司 | 包含urat1的有效抑制剂的药物组合物 |
| US12214084B2 (en) | 2017-07-11 | 2025-02-04 | Qualicaps Co., Ltd. | Enteric hard capsule |
| US11440896B2 (en) | 2018-02-06 | 2022-09-13 | Daiichi Sankyo Company, Limited | Aminoalkyl compound |
| US12280153B2 (en) | 2018-06-22 | 2025-04-22 | Qualicaps Co., Ltd. | Enteric hard capsule |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| DE19525137C2 (de) * | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE10059411A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz |
| US20050176790A1 (en) * | 2001-02-28 | 2005-08-11 | Johannes Bartholomaus | Pharmaceutical salts |
| DE10109763A1 (de) * | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
| JP4207651B2 (ja) * | 2003-05-07 | 2009-01-14 | ソニー株式会社 | 充電器 |
| DE10333835A1 (de) * | 2003-07-24 | 2005-03-10 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung |
-
2005
- 2005-09-15 US US12/066,927 patent/US20090104266A1/en not_active Abandoned
-
2006
- 2006-09-15 KR KR1020087009033A patent/KR20080059212A/ko not_active Abandoned
- 2006-09-15 NZ NZ566473A patent/NZ566473A/en not_active IP Right Cessation
- 2006-09-15 CN CNA2006800338007A patent/CN101262857A/zh active Pending
- 2006-09-15 PL PL06805729T patent/PL1928441T3/pl unknown
- 2006-09-15 SI SI200631539T patent/SI1928441T1/sl unknown
- 2006-09-15 DK DK06805729.8T patent/DK1928441T3/da active
- 2006-09-15 ES ES06805729T patent/ES2402206T3/es active Active
- 2006-09-15 CA CA002621270A patent/CA2621270A1/en not_active Abandoned
- 2006-09-15 RU RU2008114051/15A patent/RU2445081C2/ru not_active IP Right Cessation
- 2006-09-15 HR HRP20130225TT patent/HRP20130225T1/hr unknown
- 2006-09-15 BR BRPI0621466-5A patent/BRPI0621466A2/pt not_active IP Right Cessation
- 2006-09-15 JP JP2008530423A patent/JP2009507875A/ja active Pending
- 2006-09-15 PT PT68057298T patent/PT1928441E/pt unknown
- 2006-09-15 EP EP06805729A patent/EP1928441B1/de active Active
- 2006-09-15 AU AU2006291422A patent/AU2006291422B2/en not_active Ceased
- 2006-09-15 WO PCT/EP2006/008988 patent/WO2007031326A2/de not_active Ceased
-
2008
- 2008-02-28 IL IL189820A patent/IL189820A0/en unknown
- 2008-03-10 ZA ZA200802269A patent/ZA200802269B/xx unknown
- 2008-03-14 EC EC2008008285A patent/ECSP088285A/es unknown
- 2008-04-11 NO NO20081785A patent/NO20081785L/no not_active Application Discontinuation
-
2011
- 2011-10-26 US US13/282,005 patent/US20120039963A1/en not_active Abandoned
-
2013
- 2013-04-23 CY CY20131100328T patent/CY1113943T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101262857A (zh) | 2008-09-10 |
| US20120039963A1 (en) | 2012-02-16 |
| JP2009507875A (ja) | 2009-02-26 |
| RU2445081C2 (ru) | 2012-03-20 |
| EP1928441A2 (de) | 2008-06-11 |
| KR20080059212A (ko) | 2008-06-26 |
| RU2008114051A (ru) | 2010-01-20 |
| BRPI0621466A2 (pt) | 2012-09-11 |
| ES2402206T3 (es) | 2013-04-29 |
| NZ566473A (en) | 2011-05-27 |
| SI1928441T1 (sl) | 2013-04-30 |
| WO2007031326A3 (de) | 2007-06-07 |
| DK1928441T3 (da) | 2013-04-08 |
| EP1928441B1 (de) | 2013-02-27 |
| PL1928441T3 (pl) | 2013-05-31 |
| ECSP088285A (es) | 2008-04-28 |
| PT1928441E (pt) | 2013-03-18 |
| AU2006291422A1 (en) | 2007-03-22 |
| CA2621270A1 (en) | 2007-03-22 |
| NO20081785L (no) | 2008-06-02 |
| IL189820A0 (en) | 2008-11-03 |
| WO2007031326A2 (de) | 2007-03-22 |
| ZA200802269B (en) | 2008-12-31 |
| US20090104266A1 (en) | 2009-04-23 |
| AU2006291422B2 (en) | 2012-07-05 |
| HRP20130225T1 (hr) | 2013-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Extracellular vesicles derived from melatonin‐preconditioned mesenchymal stem cells containing USP29 repair traumatic spinal cord injury by stabilizing NRF2 | |
| Gai et al. | The role of mitochondria in drug-induced kidney injury | |
| CY1113943T1 (el) | Παρασκευασμα κατακρατησης 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινολης | |
| Hahm et al. | Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction | |
| Liu et al. | Vitamin D mediates its action in human colon carcinoma cells in a calcium‐sensing receptor‐dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5‐FU | |
| CY1118731T1 (el) | Φαρμακευτικες συνθεσεις αλβιγλουτιδης | |
| CY1119598T1 (el) | Ανθεκτικες σε θραυση μορφες δοσολογησης με επιβραδυντικη απελευθερωση | |
| CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
| CY1111065T1 (el) | Φαρμακευτικη συνθεση που περιεχει μια ωμεγα-καρβοξυαρυλ υποκατεστημενη διφαινυλ ουρια για τη θεραπευτικη αντιμετωπιση του καρκινου | |
| Li et al. | Inhibition of CHOP accentuates the apoptotic effect of α-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells | |
| ES2659390T3 (es) | Pastilla para chupar para uso en la reducción de la dependencia del tabaco y/o del alcohol | |
| US20150139949A1 (en) | Anti-viral combination therapy | |
| MX2011011772A (es) | Formulaicones estables de anticuerpos humanos anti-tnf-alfa con alta concentracion de proteina. | |
| US20160271137A1 (en) | Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals | |
| MY159203A (en) | Solid preparation comprising alogliptin and metformin hydrochloride | |
| BRPI0517569A (pt) | uso de um ligando, ligando, composição farmacêutica, e, dispositivo de distribuição de drogas | |
| CY1111934T1 (el) | Σταθεροποιημενες φαρμακευτικες συνθεσεις οι οποιες περιεχουν φεσοτεροδινη | |
| CY1115719T1 (el) | Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων | |
| CY1111939T1 (el) | Φαρμακευτικο στερεο παρασκευασμα που περιλαμβανει βενζαζεπινες και μεθοδος παρασκευης αυτου | |
| CL2008000021A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer. | |
| US9149445B2 (en) | Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections | |
| CY1117174T1 (el) | ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ | |
| CY1114791T1 (el) | Πιμοβενδανη για χρηση στη θεραπεια της υπερτροφικης μυοκαρδιοπαθειας σε γατες | |
| NO20074933L (no) | Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat | |
| KR20110008066A (ko) | 골량 관련 질병의 진단, 예방 및 치료 방법 |